Guinea vs Nigeria: Hepatitis B surface antigen (HBsAg) prevalence
Guinea
2.8%
in 2024
Nigeria
2.7%
in 2024
Guinea rank
7th
Nigeria rank
8th
Hepatitis B surface antigen (HBsAg) prevalence over time
- Guinea
- Nigeria
How they compare
Guinea currently reports 2.8% against 2.7% in Nigeria, a difference of 0.1%.
The two have swapped places 1 time across 10 shared years of data; in 2015 it was Nigeria ahead.
Guinea ranks 7th and Nigeria ranks 8th of 194 countries.
Nigeria has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Guinea | Nigeria | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 2.7% | 3.7% | 1.0% | Nigeria |
| 2020s | 2.7% | 3.1% | 0.4% | Nigeria |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hepatitis b surface antigen (hbsag) prevalence, Guinea or Nigeria?
- Guinea, at 2.8% against 2.7% in Nigeria as of 2024.
- What is the difference in hepatitis b surface antigen (hbsag) prevalence between Guinea and Nigeria?
- 0.1%, with Guinea ahead.
- How many years of comparable data are there for Guinea and Nigeria?
- 10 years are reported by both, from 2015 to 2024.
- How do Guinea and Nigeria rank globally for hepatitis b surface antigen (hbsag) prevalence?
- Guinea ranks 7th and Nigeria ranks 8th of 194 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Hepatitis B surface antigen (HBsAg) prevalence (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.